Trials / Completed
CompletedNCT02459535
Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- German Institute of Human Nutrition · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Furthermore, data on human subjects are sparse and controversial. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested.
Detailed description
Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Up to now, no single study has ever compared metabolic responses to different AS in the same subjects. Furthermore, data on human subjects are sparse and controversial. This is partially explained by different methodical approaches such as intragastral/intraduodenal application of AS, rather than conventional oral consumption. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested: saccharin, aspartame and sucralose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | oral stimulation glucose | oral stimulation with glucose, AS or glucose+AS in fasted state, blood samples from fasted state up to 120 min post-ingestion |
| OTHER | oral stimulation saccharin | |
| OTHER | oral stimulation aspartame | |
| OTHER | oral stimulation sucralose |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2017-06-01
- Completion
- 2019-07-01
- First posted
- 2015-06-02
- Last updated
- 2020-06-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02459535. Inclusion in this directory is not an endorsement.